Autoimmune lymphoproliferative syndrome type IIB

Gene Information

Names

HUGO name: CASP8

Alias(es):

  • FLICE
  • MACH
  • MCH5
  • FADD-homologous ICE/CED-3-like protease
  • H.sapiens mRNA for MACH-alpha-2 protein
  • MACH-alpha-1/2/3 protein
  • MACH-beta-1/2/3/4 protein
  • Mch5 isoform alpha
  • Caspase 8, apoptosis-related cysteine protease
  • Caspase-8 precursor
  • ICE-like apoptotic protease 5)
  • MORT1-associated CED-3 homolog
  • FADD-homologous ICE/CED-3- like protease
  • FADD-like ICE
  • Apoptotic cysteine protease
  • Apoptotic protease Mch-5

Localization

Reference sequences

Chromosomal location

Maps

Markers

Protein Information

Description

Protein function:

Most upstream protease of the activation cascade of caspases responsible for the TNFRSF6/FAS mediated and TNFRSF1a induced cell death. Binding to the adapter molecule fadd recruits it to either receptor. The resulting aggregate called death-inducing signaling complex (disc) performs CASP8 proteolytic activation. The active dimeric enzyme is then liberated from the disc and free to activate downstream apoptotic proteases. Proteolytic fragments of the n-terminal propeptide (termed cap3, cap5 and cap6) are likely retained in the disc. Cleaves and activates CASP3, CASP4, CASP6, CASP7, CASP9 and CASP10. May participate in the GZMB apoptotic pathways. Cleaves ADPRT. Hydrolyzes the small-molecule substrate, ac-asp-glu-val-asp-|-amc. Likely target for the cowpox virus CRMA death inhibitory protein. Isoforms 5, 6, 7 and 8 lack the catalytic site and may interfere with the pro-apoptotic activity of the complex

Subunit:

Heterodimer of a 18 kDa (p18) and a 10 kDa (p10) subunit. Interacts with fadd, cflar and pea15. Isoform 9 interacts at the endoplasmic reticulum with a complex containing bcap31, bap29, bcl2 and/or bcl2l1.

Subcellular location:

Cytoplasmic

Post-translational modification:

Generation of the subunits requires association with the death-inducing signaling complex (disc), whereas additional processing is likely due to the autocatalytic activity of the activated protease. Gzmb and CASP10 can be involved in these processing events.

Alternative products:

Event=alternative splicing; named isoforms=9; name=1; synonyms=alpha-1; isoid=q14790-1; sequence=displayed; name=2; synonyms=alpha-2, mch5-beta; isoid=q14790-2; sequence=vsp_000810; name=3; synonyms=alpha-3; isoid=q14790-3; sequence=vsp_000813; name=4; synonyms=alpha-4; isoid=q14790-4; sequence=vsp_000809, vsp_000810; name=5; synonyms=beta-1; isoid=q14790-5; sequence=vsp_000814, vsp_000815; name=6; synonyms=beta-2; isoid=q14790-6; sequence=vsp_000811, vsp_000812; name=7; synonyms=beta-3, 8l; isoid=q14790-7; sequence=vsp_000816, vsp_000817; name=8; synonyms=beta-4; isoid=q14790-8; sequence=vsp_000810, vsp_000816, vsp_000817; name=9; synonyms=8l; isoid=q14790-9; sequence=vsp_000808;

Tissue specificity:

Isoforms 1, 5 and 7 are expressed in a wide variety of tissues. Highest expression in peripheral blood leukocytes, spleen, thymus, and liver. Barely detectable in brain, testis, and skeletal muscle.

Similarity:

Belongs to peptidase family C14.

Structures (PDB)

1F9E Caspase-8 Specificity Probed At Subsite S4: Crystal Structure Of The Caspase-8-Z-Devd-Cho
1QDU Crystal Structure Of The Complex Of Caspase-8 With The Tripeptide Ketone Inhibitor Zevd-Dcbmk
1QTN Crystal Structure Of The Complex Of Caspase-8 With The Tetrapeptide Inhibitor Ace-Ietd-Aldehyde

Domains

DED 1 domain: 2-80

    DED 2 domain: 100-177

      Expression

      Expression pattern for human

      Tissue Expression (%) Clones
      human placenta 8.44 2:7218
      leukocyte 6.89 2:8838
      sciatic nerve 6.07 1:5018
      embryonal carcinoma 5.48 2:11109
      mammary adenocarcinoma, cell line 5.31 3:17218
      hypernephroma 5.26 1:5792
      bone marrow 5.23 1:5829
      moderately-differentiated adenocarcinoma 4.70 1:6478
      mucoepidermoid carcinoma 4.58 1:6654
      pre-eclamptic placenta 4.07 1:7480
      human placenta 8.44 2:7218
      leukocyte 6.89 2:8838
      sciatic nerve 6.07 1:5018
      embryonal carcinoma 5.48 2:11109
      mammary adenocarcinoma, cell line 5.31 3:17218
      hypernephroma 5.26 1:5792
      bone marrow 5.23 1:5829
      moderately-differentiated adenocarcinoma 4.70 1:6478
      mucoepidermoid carcinoma 4.58 1:6654
      pre-eclamptic placenta 4.07 1:7480